Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Inamrinone
Drug ID BADD_D01146
Description Amrinone (or inamrinone) is a type 3 pyridine phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.
Indications and Usage Not Available
Marketing Status Discontinued
ATC Code C01CE01
DrugBank ID DB01427
KEGG ID D00231
MeSH ID D000676
PubChem ID 3698
TTD Drug ID D0R6TI
NDC Product Code 63660-0003
Synonyms Amrinone | Amrinon | 5-Amino-(3,4'-bipyridine)-6(1H)-one | Wincoram | Win-40680 | Win 40680 | Win40680 | Cordemcura | Inocor
Chemical Information
Molecular Formula C10H9N3O
CAS Registry Number 60719-84-8
SMILES C1=CN=CC=C1C2=CNC(=O)C(=C2)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Arrhythmia02.03.02.001--Not Available
Ascites09.01.05.003; 07.07.01.001; 02.05.04.002--
Chest pain08.01.08.002; 02.02.02.011; 22.02.08.003--Not Available
Hepatotoxicity12.03.01.008; 09.01.07.009--Not Available
Hypotension24.06.03.002--
Hypoxia22.02.02.003--
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Jaundice01.06.04.004; 23.03.03.030; 09.01.01.004--Not Available
Myositis15.05.01.001--
Nausea07.01.07.001--
Pericarditis02.06.02.001--
Platelet count decreased13.01.04.001--
Pleurisy22.05.01.001--Not Available
Pyrexia08.05.02.003--
Vasculitis24.05.02.001; 10.02.02.006--
Vomiting07.01.07.003--
Decreased appetite14.03.01.005; 08.01.09.028--
The 1th Page    1    Total 1 Pages